228 related articles for article (PubMed ID: 32495322)
1. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.
Kaplan KA; Elsea SH; Potocki L
CNS Drugs; 2020 Jul; 34(7):723-730. PubMed ID: 32495322
[TBL] [Abstract][Full Text] [Related]
2. [Sleep disturbances in Smith-Magenis syndrome: treatment with melatonin and beta-adrenergic antagonists].
Van Thillo A; Devriendt K; Willekens D
Tijdschr Psychiatr; 2010; 52(10):719-23. PubMed ID: 20931486
[TBL] [Abstract][Full Text] [Related]
3. [Sleep disturbance associated with Smith-Magenis syndrome].
Pan M; Chen L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1262-1265. PubMed ID: 34839521
[TBL] [Abstract][Full Text] [Related]
4. Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.
Poisson A; Nicolas A; Cochat P; Sanlaville D; Rigard C; de Leersnyder H; Franco P; Des Portes V; Edery P; Demily C
Orphanet J Rare Dis; 2015 Sep; 10():111. PubMed ID: 26336863
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.
Smith ACM; Morse RS; Introne W; Duncan WC
Am J Med Genet A; 2019 Feb; 179(2):224-236. PubMed ID: 30690916
[TBL] [Abstract][Full Text] [Related]
6. Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways.
Elsea SH; Williams SR
Expert Rev Mol Med; 2011 Apr; 13():e14. PubMed ID: 21545756
[TBL] [Abstract][Full Text] [Related]
7. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.
Williams SR; Zies D; Mullegama SV; Grotewiel MS; Elsea SH
Am J Hum Genet; 2012 Jun; 90(6):941-9. PubMed ID: 22578325
[TBL] [Abstract][Full Text] [Related]
8. [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].
De Leersnyder H; de Blois MC; Bresson JL; Sidi D; Claustrat B; Munnich A
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S21-6. PubMed ID: 14646795
[TBL] [Abstract][Full Text] [Related]
9. First Case Report of Smith-Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview.
Nijim Y; Adawi A; Bisharat B; Bowirrat A
Medicine (Baltimore); 2016 Jan; 95(3):e2362. PubMed ID: 26817868
[TBL] [Abstract][Full Text] [Related]
10. [Smith-Magenis syndrome is an association of behavioral and sleep/wake circadian rhythm disorders].
Poisson A; Nicolas A; Sanlaville D; Cochat P; De Leersnyder H; Rigard C; Franco P; des Portes V; Edery P; Demily C
Arch Pediatr; 2015 Jun; 22(6):638-45. PubMed ID: 25934608
[TBL] [Abstract][Full Text] [Related]
11. Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder.
Poisson A; Nicolas A; Bousquet I; Raverot V; Gronfier C; Demily C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330985
[TBL] [Abstract][Full Text] [Related]
12. Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic
Linders CC; van Eeghen AM; Zinkstok JR; van den Boogaard MJ; Boot E
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628566
[TBL] [Abstract][Full Text] [Related]
13. beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
De Leersnyder H; de Blois MC; Vekemans M; Sidi D; Villain E; Kindermans C; Munnich A
J Med Genet; 2001 Sep; 38(9):586-90. PubMed ID: 11546826
[TBL] [Abstract][Full Text] [Related]
14. Smith-Magenis syndrome.
De Leersnyder H
Handb Clin Neurol; 2013; 111():295-6. PubMed ID: 23622179
[TBL] [Abstract][Full Text] [Related]
15. Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity - own experience.
Chen L; Mullegama SV; Alaimo JT; Elsea SH
Dev Period Med; 2015; 19(2):149-56. PubMed ID: 26384114
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.
Vilboux T; Ciccone C; Blancato JK; Cox GF; Deshpande C; Introne WJ; Gahl WA; Smith AC; Huizing M
PLoS One; 2011; 6(8):e22861. PubMed ID: 21857958
[TBL] [Abstract][Full Text] [Related]
17. Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention.
Spruyt K; Braam W; Smits M; Curfs LM
CNS Neurosci Ther; 2016 Nov; 22(11):928-935. PubMed ID: 27743421
[TBL] [Abstract][Full Text] [Related]
18. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.
Mullegama SV; Pugliesi L; Burns B; Shah Z; Tahir R; Gu Y; Nelson DL; Elsea SH
Eur J Hum Genet; 2015 Jun; 23(6):781-9. PubMed ID: 25271084
[TBL] [Abstract][Full Text] [Related]
19. Smith Magenis syndrome: First case of congenital heart defect in a patient with Rai1 mutation.
Onesimo R; Delogu AB; Blandino R; Leoni C; Rosati J; Zollino M; Zampino G
Am J Med Genet A; 2022 Jul; 188(7):2184-2186. PubMed ID: 35373511
[TBL] [Abstract][Full Text] [Related]
20. Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome.
Huang WH; Wang DC; Allen WE; Klope M; Hu H; Shamloo M; Luo L
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10744-10749. PubMed ID: 30275311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
